GAINESVILLE, Fla. — A University of Florida researcher with a $2 million federal grant is launching the first Phase III clinical trial for treatment of a congenital disease of the mitochondria, the energy powerhouse of cells. A Phase III trial assesses a treatment’s efficacy in patients and is one of the last steps necessary before…
